Related content

PET imaging with [C]methyl-L-methionine for therapy monitoring in patients with rectal cancer

By Wieder Hinrich   Ott Katja   Zimmermann Frank   Nekarda Hjalmar   Stollfuß Jens   Watzlowik Petra   Siewert Jörg-Rüdiger   Fink Ulrich   Becker Karen   Schwaiger Markus   Weber Wolfgang Andreas  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 29, Iss. 6, 2002-06 ,pp. : 789-796

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET

By Stahl A.   Ott K.   Schwaiger M.   Weber W.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 11, 2004-11 ,pp. : 1471-1478

Springer Publishing Company

Access to resources Recommend Favorite

Role of Molecular Signatures in Effective Cancer Therapy

By KOLA ISMAIL  

Toxicologic Pathology, Vol. 32, Iss. 6, 2004-11 ,pp. : 736-736

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Biological imaging for selecting and monitoring cancer therapy; a pathway to individualised therapy

By Schwaiger Markus   Peschel Christian  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, Iss. 1, 2006-07 ,pp. : 1-5

Springer Publishing Company

Access to resources Recommend Favorite

Early therapy monitoring with FDG-PET in aggressive non-Hodgkin’s lymphoma and Hodgkin’s lymphoma

By Torizuka Tatsuo   Nakamura Fumitoshi   Kanno Toshihiko   Futatsubashi Masami   Yoshikawa Etsuji   Okada Hiroyuki   Kobayashi Masahide   Ouchi Yasuomi  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 1, 2004-01 ,pp. : 22-28

Springer Publishing Company

Access to resources Recommend Favorite